Final Program Introduction of CVRF
| Date | Time | Place | Session / Title | Role |
| April 29 | 10:30 AM - 12:25 PM | Room 104, Level 1 | DES & New BRS | Panelist |
| April 29 | 11:02 AM - 11:10 AM | Room 104, Level 1 | DES & New BRS Rethinking DAPT Duration with Smarter DES: Personalized vs. Generalized Strategy |
Lecturer |
| April 29 | 3:20 PM - 4:40 PM | Abstract Zone II, Level 1 | 2-2. Complex PCI | Panelist |
| April 30 | 7:00 AM - 8:00 AM | Room 105, Level 1 | Antithrombotic Therapy | Panelist |
| April 30 | 2:00 PM - 3:06 PM | Room 104, Level 1 | Spotlights of Major Clinical Studies with Expert Commentary | Discussant |
| April 30 | 2:40 PM - 2:44 PM | Room 104, Level 1 | Spotlights of Major Clinical Studies with Expert Commentary Discussion: Why DAPT Trial Not Followed?: Moving Forward Less Duration with Smart DES, De-Escalating Strategy, and P2Y12 Inhibitor Monotherapy |
Discussant |
| April 30 | 2:55 PM - 3:02 PM | Room 104, Level 1 | Spotlights of Major Clinical Studies with Expert Commentary Multivessel PCI in AMI and Cardiogenic Shock: SHOCK Trial Series Review and Real-World Application |
Lecturer |
| April 30 | 3:06 PM - 4:56 PM | Room 104, Level 1 | 2018 New Data from AMC; Novel and More with Expert Commentary | Discussant |
| April 30 | 4:19 PM - 4:23 PM | Room 104, Level 1 | 2018 New Data from AMC; Novel and More with Expert Commentary Discussion: OPTIMA Trial: P2Y12 Dose Adjustment for East-Asian ACS Patients |
Discussant |
